Gottlieb, Alice B., et al. “Long-Term Safety of Secukinumab Over Five Years in Patients With Moderate-to-Severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-Marketing Surveillance Data”. Acta Dermato-Venereologica, vol. 102, Apr. 2022, p. adv00698, doi:10.2340/actadv.v102.563.